Abstract
Poliovirus caused several major epidemics in the early 1950's that resulted in about 21,000 cases per year in the United States. In 1955, an inactivated polio vaccine was developed that limited the spread of this feared disease. The Salk vaccine, combined with a live virus vaccine produced by Sabin, plus a comprehensive eradication campaign, have eliminated wild type poliomyelitis in the United States. However, there remain many patients who suffer from the sequelae of this disease through permanent paralysis and post-polio syndrome.
| Original language | English (US) |
|---|---|
| Title of host publication | xPharm |
| Subtitle of host publication | The Comprehensive Pharmacology Reference |
| Publisher | Elsevier Inc. |
| Pages | 1-4 |
| Number of pages | 4 |
| ISBN (Print) | 9780080552323 |
| DOIs | |
| State | Published - Dec 1 2011 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics(all)
Cite this
Poliomyelitis. / Vander, Elizabeth Top; Gentry-Nielsen, Martha; Knoop, Floyd C.
xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., 2011. p. 1-4.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Poliomyelitis
AU - Vander, Elizabeth Top
AU - Gentry-Nielsen, Martha
AU - Knoop, Floyd C.
PY - 2011/12/1
Y1 - 2011/12/1
N2 - Poliovirus caused several major epidemics in the early 1950's that resulted in about 21,000 cases per year in the United States. In 1955, an inactivated polio vaccine was developed that limited the spread of this feared disease. The Salk vaccine, combined with a live virus vaccine produced by Sabin, plus a comprehensive eradication campaign, have eliminated wild type poliomyelitis in the United States. However, there remain many patients who suffer from the sequelae of this disease through permanent paralysis and post-polio syndrome.
AB - Poliovirus caused several major epidemics in the early 1950's that resulted in about 21,000 cases per year in the United States. In 1955, an inactivated polio vaccine was developed that limited the spread of this feared disease. The Salk vaccine, combined with a live virus vaccine produced by Sabin, plus a comprehensive eradication campaign, have eliminated wild type poliomyelitis in the United States. However, there remain many patients who suffer from the sequelae of this disease through permanent paralysis and post-polio syndrome.
UR - http://www.scopus.com/inward/record.url?scp=84883900388&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883900388&partnerID=8YFLogxK
U2 - 10.1016/B978-008055232-3.60926-2
DO - 10.1016/B978-008055232-3.60926-2
M3 - Chapter
AN - SCOPUS:84883900388
SN - 9780080552323
SP - 1
EP - 4
BT - xPharm
PB - Elsevier Inc.
ER -